Interv Akut Kardiol. 2010;9(2):81-85
Infective endokarditis (IE) remains a very serious illness and neither the incidence nor the mortality have decreased in the past decades.
Eradication of microbes by antimicrobial drugs is the cornerstone of successful treatment. Antibiotic treatment should be targeted on the
basis of positive blood cultures. Cell wall inhibitors (β-lactams, glycopeptides) in combination with aminoglycosides are used the most
frequently. Surgery is indicated in approximately fifty percent of patiens because of severe complications (heart failure, uncontrolled
infection, prevention of systemic embolism). Because of the complexity of that illness, multispecialty approach is necessary. Updated
recommendations for prevention of IE have dramatically changed long-established practise. Antibiotic prophylaxis is now advised only
for the highest risk patients undergoing the highest risk dental procedures.
Published: April 1, 2010 Show citation